One co-investigator (G.L.)assessed this XRCC1 SNP in patients with esophageal cancer treated with cisplatin-based trimodality therapy and, similar to the current study, did not find an association with disease-free or overall survival[36]. Here, XRCC1 is linked to esophageal cancer.